Salvini, M., Damonte, C., Mortara, L., Maggi, F., Bruno, A., Pellegrini, G., et al. (2022). Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients. AMERICAN JOURNAL OF HEMATOLOGY, 97(8), 321-324 [10.1002/ajh.26629].

Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients

Franchi M.;
2022

Lettera in rivista
Immunogenicity, SARS-CoV-2, COVID-19 vaccination, hematological malignancies
English
15-giu-2022
2022
97
8
321
324
none
Salvini, M., Damonte, C., Mortara, L., Maggi, F., Bruno, A., Pellegrini, G., et al. (2022). Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients. AMERICAN JOURNAL OF HEMATOLOGY, 97(8), 321-324 [10.1002/ajh.26629].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/416037
Citazioni
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
Social impact